Skip to content

Author

P. Ďurina

We have 1 of 6 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Aromatase inhibitors as endocrine modulators: from breast cancer therapy to male off-label use and doping practice.

Aromatase inhibitors (AIs) suppress estrogen biosynthesis by blocking the conversion of androgens to estrogens. Although they are established endocrine therapies in postmenopausal breast cancer, their mechanism has led to off-label and non-medical use in men, including performance-enhancing drug practices, post-cycle t...

A. Bandura, P. Ďurina, Enrico Čambál et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.